. 2019 Mar 5;11(3):309. doi: 10.3390/cancers11030309

Table 2.

Mean relative abundance of 10 KEGG pathways and six KEGG orthologies (KOs).

KEGG Pathway	Pathway Name	Normal	CIN2/3	Cervical Cancer	p ^a	KEGG Orthology	KO Name	Normal	CIN2/3	Cervical Cancer	p ^a
ko00550	Peptidoglycan biosynthesis	0.8881	1.1465	2.9481	0.0382
ko00300	Lysine biosynthesis	0.4785	0.5669	0.2940	0.0084	K00215	4-Hydroxy-tetrahydrodipicolinate reductase	0.0334	0.0380	0.0055	0.0146
ko00300	Lysine biosynthesis	0.4785	0.5669	0.2940	0.0084	K01778	Diaminopimelate epimerase	0.0202	0.0271	0.0036	0.0199
ko00680	Methane metabolism	0.7161	0.7716	0.4996	0.0049	K00625	Phosphate acetyltransferase	0.0831	0.0997	0.0407	0.0289
ko00680	Methane metabolism	0.7161	0.7716	0.4996	0.0049	K01007	Pyruvate, water dikinase	0.0203	0.0243	0.0036	0.0361
ko05211	Renal cell carcinoma	0.0244	0.0327	0.0030	0.0095	K01679	Fumarate hydratase, class II	0.0284	0.0322	0.0073	0.0318
ko05111	Biofilm formation in Vibrio cholerae	0.3439	0.2532	0.1552	0.0174
ko00621	Dioxin degradation	0.0296	0.0204	0	0.0042	K01821	4-Oxalocrotonate tautomerase	0.0202	0.0167	0	0.0044
ko00362	Benzoate degradation	0.1100	0.1027	0.0421	0.0104	K01821	4-Oxalocrotonate tautomerase	0.0202	0.0167	0	0.0044
ko00460	Cyanoamino acid metabolism	0.1251	0.1093	0.0502	0.0090
ko00622	Xylene degradation	0.0320	0.0204	0.0044	0.0172	K01821	4-Oxalocrotonate tautomerase	0.0202	0.0167	0	0.0044
ko00643	Styrene degradation	0.0939	0.0596	0.0339	0.0177

^ap value calculated by Kruskal–Wallis test.